Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy.

Roulet, Lucien; Bedatsova, Lucia; Merz, Laurent; Desmeules, Jules; Saiah, Lila

Roulet, Lucien; Bedatsova, Lucia; Merz, Laurent; Desmeules, Jules; Saiah, Lila.

Afiliación

Roulet L; Division of Clinical Pharmacy, Hospital Pharmacy of Nord Vaudois and Broye Region, 1400 Yverdon-les-Bains, Switzerland. Electronic address: lucien.roulet@gmail.com.
Bedatsova L; Treatment and Rehabilitation Centre, Hospitals of Nord Vaudois, 1436 Chamblon, Switzerland.
Merz L; Division of Internal Medicine, Hospitals of Nord Vaudois, 1318 Pompaples, Switzerland.
Desmeules J; Division of Clinical Pharmacology and Toxicology, Department of Anesthesiology, Pharmacology, Emergency Medicine and Intensive Care, Geneva University Hospitals and Geneva University, 1205 Geneva, Switzerland.
Saiah L; Treatment and Rehabilitation Centre, Hospitals of Nord Vaudois, 1436 Chamblon, Switzerland.

Therapie ; 78(3): 338-342, 2023.

Article en En | MEDLINE | ID: mdl-35907681

Asunto(s)

Enfermedades Intestinales; Humanos; Imidazoles/efectos adversos; Tetrazoles/efectos adversos; Diarrea

Palabras clave

Angiotensin II receptor blocker; Hospitalisation; Olmesartan; Rechallenge; Sprue-like enteropathy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Intestinales Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Therapie Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google